Chevy Chase Trust’s Opko Health OPK Stock Holding History

Chevy Chase Trust’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-825	Closed	-$1K	–	904
2019 Q4	$1K	Buy	+825	New	+$1.38K	﹤0.01%	1153

Other funds holding OPK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Chevy Chase Trust's OPK Position: Q1 2020 in Review

Chevy Chase Trust sold out of Opko Health (OPK) in Q1 2020, closing a stake of 825 shares — an estimated $1K sold.

Chevy Chase Trust first reported a position in OPK in Q4 2019 and held it in 1 quarter. The position peaked at $1K in Q4 2019. 181 funds tracked by Wall St. Rank hold OPK as of Q1 2020.

Chevy Chase Trust reported no remaining Opko Health position as of Q1 2020 after selling out during the quarter.
Chevy Chase Trust sold 825 Opko Health shares in Q1 2020, an estimated $1K.
Chevy Chase Trust first reported a position in Opko Health in Q4 2019 and held it in 1 quarter.
Chevy Chase Trust's Opko Health position peaked at $1K in Q4 2019.
181 funds tracked by Wall St. Rank held Opko Health as of Q1 2020.

Based on Chevy Chase Trust's 13F filing for Q1 2020, filed 13 May 2020.